Clinical trial
WCC# 59: Pilot Study of Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence
NCT01144442 is registered in ClinicalTrials.gov with Masonic Cancer Center, University of Minnesota as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- WCC# 59: Pilot Study of Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence
- Lead sponsor
- Masonic Cancer Center, University of Minnesota
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- July 27, 2010
- Completion date
- May 1, 2015
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
fallopian tube cancer, ovarian cancer, peritoneal carcinoma